Abstract
PURPOSE: In patients of bronchial asthma not adequately controlled by inhaled corticosteroids (ICS) alone, the addition of long acting beta agonists is recommended. We evaluated the safety and efficacy of a new HFA propelled pressurized metered dose inhaler (pMDI) containing a combination of Fluticasone and Formoterol compared to the combination of Budesonide/Formoterol.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
